| 摘要 |
An adhesive polymeric composition of matrix transdermal therapeutic system comprises polyvinyl pyrrolidone of molecular weight of 12,500, polyvinyl pyrrolidone of molecular weight of 360,000, polyoxyethylene-400 and glycerin as flexibilizers, ethyl alcohol, purified water and propylene glycol as solvents. |
